Mary Vanac is a co-founder of MedCity News.
Mardil, one of the newest companies based in Minnesota, wants to create a new innovative medical device that treats sloppy mitral valves short of doing open-heart surgery. It is trying to raise up to $12 million.
Dell said it will acquire Insite One, a developer of applications that enables doctors to share medical images in the cloud, for an undisclosed price, reports VentureBeat.
Detroit Venture Partners wants its portfolio companies to move their operations to the heart of Detroit in the hopes of transforming the Motor City into a vibrant startup community like Boston and San Francisco, according to Xconomy Detroit.
The dealmaking machine that is Sanofi-Aventis is at it again, signing an oncology drug pact with Avila Therapeutics in Waltham, Massachusetts, worth $40 million up front and up to $154 million in milestone payments per program. Overall, the deal is valued at $800 million, according to FierceBiotech.
As medical schools wrestle with how to keep drug companies from corrupting their faculties, Stanford University often is lauded for its tough stance. But a ProPublica investigation found that more than a dozen of the school's doctors were
The artificial pancreas just got a brain. Medtronic Inc. (NYSE:MDT) said Monday the Food and Drug Administration has approved software that helps manage a patient's diabetes therapy.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The Food and Drug Administration on Thursday moved toward revoking approval of the blockbuster cancer drug Avastin as a treatment for breast cancer, drawing criticism for limiting treatment options for desperately ill women, reports the Chicago Tribune.
As the history of social legislation suggests -- and as this week's federal court ruling on the so-called individual mandate makes clear, the effects of healthcare reform on our politics may not be settled until a lot of President Obama's aides are collecting Medicare checks, according to the New York Times.
The U.S. Constitution's Commerce Clause states that Congress has the power to "regulate Commerce … among the several States." To supporters of health reform, the Commerce Clause is the Grinch that stole Obamacare, writes the Health Care Blog. To opponents, it might seem like a Sanity Clause.
The Ohio Controlling Board today approved Theken Spine LLC for a $200,000 Rapid Outreach grant to buy new machinery and equipment. The Akron maker of implantable hardware for spinal fusion surgery is consolidating four facilities at a Medina building, which will be renovated and used for offices, warehousing and product manufacturing.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Cleveland Clinic spinoff Clear Catheter Systems, which recently closed a $1.2 million angel investment round, has received FDA approval to sell its PleuraFlow Active Tube-Clearance System in the United States. PleuraFlow keeps catheters clear while draining blood and other fluids from the chest after heart or lung surgery.
Unequal access to healthcare is hardly a new phenomenon in the United States, but the country is moving toward rationing at an unprecedented pace. The underlying problem is that doctors are reimbursed at different rates, reports the New York Times.
A bipartisan group of 15 senators sent a letter to FDA Commissioner Dr. Margaret Hamburg urging her agency, among other things, to adopt a more deliberate, cautious approach to amending 510(k). And Orthopedics company Stryker Corp. has agreed to sell a product line including the bone growth putty that has caused the company so much legal grief to Olympus Corp. for $60 million.
The long-awaited groundbreaking for Cleveland's $465 million medical mart project will be... drum roll, please... Jan. 14, 2011. The ceremonial turning of the ground "on the historic Cleveland Malls" will happen at 11 a.m. that Friday, according to MMPI, the Chicago-based property developer that's leading the project. The event, which also will feature remarks from civic, business and government leaders, is free and open to the public.
The U.S. House gave final approval on Thursday to a bill that would avert a 25 percent cut in Medicare payments to doctors by freezing reimbursement rates at current levels until the end of next year, reports the New York Times. President Obama, who hailed the nearly unanimous action by Congress, promised to sign the legislation.
